Stock Exchange
Genmab A/S is listed on the OMX Nordic Exchange Copenhagen A/S and is a
member of the Nordic Large Cap index and OMXC20 index.
ID code/ISIN: DKK0010272202
Stock Symbol: GEN
Stock Information
Number of shares: 44,583,648
Nominal value per share: DKK 1
Share capital: DKK 44,583,648
Shareholders holding more than 5% of the shares:
GenPharm International, Inc.
Glaxo Group Ltd.
Go Capital Asset Management bv, Global Opportunities Fund
|
Subsidiary
Companies
|
Genmab B.V. (Netherlands)
|
|
|
Genmab, Inc. (United States)
|
|
|
Genmab MN, Inc. (United States)
|
|
|
Genmab Ltd. (United Kingdom)
|
|
|
|
|
Auditors
|
PricewaterhouseCoopers
|
|
|
|
|
Principal Law Firms
|
Shearman & Sterling LLP
|
|
|
Kromann Reumert
|
|
Key Dates
|
|
|
Founded
|
February 1999
|
|
First capitalization
|
February 25, 1999
|
|
IPO
|
October 18, 2000
|
|
Private Placement
|
July 1, 2004
|
|
Private Placement
|
January 27, 2006
|
|
Most recent Annual Report
|
March 31, 2008
|
|
Most recent Annual General Meeting
|
April 23, 2008
|
|
Financial Calendar year-end
|
December 31, 2008
|